Kai Habben

A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors

Razelle Kurzrock, Amita Patnaik, Joseph Aisner et al. · Clinical Cancer Research · 2010 · 195 citations

Pharmacy, Oncology, Pharmacology +16

Standardization of HER2 testing: results of an international proficiency-testing ring study

Mitch Dowsett, Wedad Hanna, Mark Kockx et al. · Modern Pathology · 2007 · 135 citations · Full text

Education, Educational Assessment, Standardized Testing +6

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, David R. Spigel, David Chen et al. · Journal of Clinical Oncology · 2011 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment

Suzanne Drury, Simone Detre, Alexandra Léary et al. · Endocrine Related Cancer · 2011 · 79 citations · Full text

Medicine, Cancer Biology, Oncology +17

Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma

Ulrik Lassen, Olivier Chinot, Catherine McBain et al. · Neuro-Oncology · 2015 · 41 citations · Full text

Medicine, Oncology, Pharmacotherapy +16